Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Aegerion Pharmaceuticals provides update on lomitapide NDA

March 12, 2012

Palatin Technologies completes enrollment in phase IIb bremelanotide trial

March 9, 2012

New diacylglycerol O-acyltransferase 1 inhibitors reported by Merck & Co.

March 8, 2012

Plant-derived lactic acid bacteria may help combat obesity

March 8, 2012

Novel tablet for type 2 diabetes available in U.S. pharmacies

March 8, 2012

Roche discovers new HSL inhibitors

March 8, 2012

New sodium/glucose cotransporter 2 inhibitors developed in China

March 8, 2012

Madrigal launches new phase I trial of cholesterol-lowering agent

March 7, 2012

Advinus Therapeutics announces novel glucokinase activators

March 7, 2012

FDA issues complete response letter for ezetimibe/atorvastatin tablets

March 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...